Abstract
Polymyxin B nonapeptide, derived by cleavage of the fatty acyl diaminobutyric acid from polymyxin B, is considerably less toxic, lacks bactericidal activity, and retains its ability to render gram-negative bacteria susceptible to several antibiotics by permeabilizing their outer membranes. The peptide rendered all 53 polymyxin-susceptible strains tested more susceptible to novobiocin, lowering the MIC of novobiocin eightfold or more. The combination of polymyxin B nonapeptide with novobiocin or with erythromycin administered intraperitoneally in multiple doses synergistically protected mice infected with gram-negative bacteria. This combination may be clinically useful because of the apparent rarity of the acquisition of resistance.
Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- Athamna A., Ofek I., Keisari Y., Markowitz S., Dutton G. G., Sharon N. Lectinophagocytosis of encapsulated Klebsiella pneumoniae mediated by surface lectins of guinea pig alveolar macrophages and human monocyte-derived macrophages. Infect Immun. 1991 May;59(5):1673–1682. doi: 10.1128/iai.59.5.1673-1682.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bauer A. W., Kirby W. M., Sherris J. C., Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol. 1966 Apr;45(4):493–496. [PubMed] [Google Scholar]
- Danner R. L., Joiner K. A., Rubin M., Patterson W. H., Johnson N., Ayers K. M., Parrillo J. E. Purification, toxicity, and antiendotoxin activity of polymyxin B nonapeptide. Antimicrob Agents Chemother. 1989 Sep;33(9):1428–1434. doi: 10.1128/aac.33.9.1428. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Duwe A. K., Rupar C. A., Horsman G. B., Vas S. I. In vitro cytotoxicity and antibiotic activity of polymyxin B nonapeptide. Antimicrob Agents Chemother. 1986 Aug;30(2):340–341. doi: 10.1128/aac.30.2.340. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kuehne R. W. Rapid determination of log10 50% lethal doses or 50% infective doses. J Clin Microbiol. 1983 Apr;17(4):702–703. doi: 10.1128/jcm.17.4.702-703.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lam C., Hildebrandt J., Schütze E., Wenzel A. F. Membrane-disorganizing property of polymyxin B nonapeptide. J Antimicrob Chemother. 1986 Jul;18(1):9–15. doi: 10.1093/jac/18.1.9. [DOI] [PubMed] [Google Scholar]
- Søgaard H. The pharmacodynamics of polymyxin antibiotics with special reference to drug resistance liability. J Vet Pharmacol Ther. 1982 Dec;5(4):219–231. doi: 10.1111/j.1365-2885.1982.tb00437.x. [DOI] [PubMed] [Google Scholar]
- Vaara M. Agents that increase the permeability of the outer membrane. Microbiol Rev. 1992 Sep;56(3):395–411. doi: 10.1128/mr.56.3.395-411.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Vaara M., Vaara T. Polycations as outer membrane-disorganizing agents. Antimicrob Agents Chemother. 1983 Jul;24(1):114–122. doi: 10.1128/aac.24.1.114. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Vaara M., Vaara T. Polycations sensitize enteric bacteria to antibiotics. Antimicrob Agents Chemother. 1983 Jul;24(1):107–113. doi: 10.1128/aac.24.1.107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Vaara M., Vaara T. Sensitization of Gram-negative bacteria to antibiotics and complement by a nontoxic oligopeptide. Nature. 1983 Jun 9;303(5917):526–528. doi: 10.1038/303526a0. [DOI] [PubMed] [Google Scholar]
- Viljanen P., Vaara M. Susceptibility of gram-negative bacteria to polymyxin B nonapeptide. Antimicrob Agents Chemother. 1984 Jun;25(6):701–705. doi: 10.1128/aac.25.6.701. [DOI] [PMC free article] [PubMed] [Google Scholar]